Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,152.01
(
-2.64%
)
News Focus
News Focus
Post# of 517118
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4002
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: BAR123 post# 509420

Saturday, 11/22/2025 9:02:18 PM

Saturday, November 22, 2025 9:02:18 PM

Post# of 517118
BAR123, we need the company to make the decisions that anyone with new and vastly improved standard-of-care therapeutics would do: run 2 well-designed, fully powered P3 trials for each incredibly good molecule.

But, CM should stay where he is. And $800K per year is chicken feed if you are a CEO in NYC. I would say it is a bargain but it is only a bargain if the CEO makes the right decisions.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News